Search clinical trials for: albuterol/salbutamol

Total 454 results

Assistance Publique - Hôpitaux de Paris

Completed

Study of Dose-response to Bronchodilator and Dose-finding in Child 2.5 to 6 Years - Study Golden (DORESI)

Asthma

France
Canisius-Wilhelmina Hospital

Recruiting

In Vivo Efficacy of Salbutamol (Sandoz) Versus Salbutamol Ventolin (GSK) in Children With Asthma (Salsa)

Asthma in Children | Agents, Anti Asthmatic

Netherlands
University Diego Portales
Clínica Vespucio, Santiago, Chile

Unknown

Hypertonic Saline for Outpatient Bronchiolitis (Hypertonic)

Bronchiolitis | Respiratory Distress

Chile
GlaxoSmithKline

Completed

Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers.

Asthma

Australia
Oregon Health and Science University

Completed

Preterm Infant Inhaled Albuterol Dosing

Bronchopulmonary Dysplasia | Very Low Birth Weight

United States
Imperial College London
National Institute for Health Research, United Kingdom

Completed

Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)

ASTHMA | CHRONIC OBSTRUCTIVE PULMONARY DISEASE | HEALTHY SUBJECTS

United Kingdom
Vastra Gotaland Region

Enrolling by invitation

Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment (COMPIS)

Musculoskeletal Diseases | Neuromuscular Diseases | Centronuclear Myopathy | Nemaline Myopathy | Congenital Myopathy | Myosin Storage Myopathy

Sweden
Chiesi Farmaceutici S.p.A.

Completed

Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma

Bronchial Asthma

Spain, Italy, Russian Federation, Ukraine
GlaxoSmithKline

Completed

First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3511294 Administered Subcutaneously (SC) in Subjects With Mild to Moderate Asthma

Asthma

United Kingdom, Germany
Children's Hospital of Philadelphia

Completed

Aerosolized Albuterol Use in Severe BPD

Severe Bronchopulmonary Dysplasia

United States
GlaxoSmithKline

Completed

An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients

Pulmonary Disease, Chronic Obstructive

Germany, Spain, United States, United Kingdom
University of Aleppo

Recruiting

Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.

Hyperkalemia

Syrian Arab Republic
University of Saskatchewan

Recruiting

Reversibility of Methacholine Induced Bronchoconstriction

Asthma

Canada
Assiut University

Unknown

Hypertonic Saline Inhalation in Acute Bronchiolitis

Acute Bronchiolitis
Medical University of Gdansk

Completed

Nebulized Bronchodilators and Cardiac Repolarization

Influence of Nebulized Bronchodilatators on Selected | Electrophysiological Parameters

Poland
University of Dundee

Withdrawn

Peak Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol (NAI007)

Asthma

United Kingdom
GlaxoSmithKline

Completed

Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients

Asthma

United States, Argentina, France, Germany, Spain, Canada, Sweden, Netherlands, Belgium
GlaxoSmithKline

Completed

A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States
GlaxoSmithKline

Completed

A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium

Pulmonary Disease, Chronic Obstructive

United States, United Kingdom
Suez Canal University

Completed

Salbutamol Administration by Nebulizer Versus Metered Dose Inhaler With Spacer in Asthma in Children

Bronchial Asthma

Egypt
GlaxoSmithKline

Not yet recruiting

A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants 12 Years of Age and Older With Asthma

Asthma

Argentina, United States, Canada, Panama, Greece, France, Poland, Italy, United Kingdom
UMC Utrecht
KU Leuven; Maastricht University Medical Center; Universiteit Antwerpen; Université...

Withdrawn

Bronchodilators for Wheeze in Young Children Presenting to Primary Care: a Randomised, Placebo-controlled, Multicentre, Parallel Group Trial (KIWI)

Wheezing
GlaxoSmithKline

Not yet recruiting

A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive

Asthma | Mild Asthma
GlaxoSmithKline

Completed

Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants

Asthma

Netherlands
Boehringer Ingelheim

Completed

A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg)

Asthma

Philippines
Sanofi
Regeneron Pharmaceuticals

Completed

Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)

Asthma

Spain, Canada, United States, Korea, Republic of, Mexico, Brazil, Germany, Taiwan, Argentina, Australia, Colombia, France, Hungary, Japan, Poland, Russian Federation, South Africa, Turkey, Ukraine, United Kingdom, Italy, Chile
Kern Medical Center

Unknown

Trial of Epinephrine and Albuterol in Bronchiolitis

Bronchiolitis

United States
GlaxoSmithKline

Withdrawn

A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma

Asthma
Boehringer Ingelheim

Completed

Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD

Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline

Completed

A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Germany, Netherlands, Greece, Czechia
GlaxoSmithKline

Completed

A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma

Asthma

United States, Germany, Bulgaria, Peru, Mexico, Poland
Nantes University Hospital

Recruiting

Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia (InSaKa)

Hyperkalemia

France
AstraZeneca

Completed

Single Dose Study to Assess Efficacy, Safety and Tolerability of LAS100977 in Asthmatic Patients.

Asthma

Germany, United Kingdom
Verona Pharma plc

Completed

The Effects of RPL554 on Top of Standard COPD Reliever Medications

Chronic Obstructive Pulmonary Disease

United Kingdom
Hat Yai Medical Education Center

Recruiting

Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study) (PARASMA)

Asthma | Airway Obstruction | Airway Remodeling | Parasympathetic Nervous System Diseases

Thailand
Boehringer Ingelheim

Completed

Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm

Asthma
GlaxoSmithKline

Not yet recruiting

A Study to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152A (Test) or HFA-134A (Reference) in Healthy Participants Aged 18 to 55 Inclusive

Asthma | Healthy Participants

Netherlands
Ain Shams University

Completed

Nebulized Heparin and Salbutamol in Mechanically Ventilated Patients With AECOPD

Mechanically Ventilated Patients

Egypt
Chiesi Farmaceutici S.p.A.

Completed

As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma

Asthma

Spain, Austria, Italy, Poland
Organon and Co
Integrated Therapeutics Group

Completed

Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)

Asthma | Rhinitis, Allergic, Seasonal
Imperial College London
GlaxoSmithKline

Terminated

Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways Disease

Chronic Obstructive Pulmonary Disease

United Kingdom
GlaxoSmithKline

Completed

Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma

Asthma

Poland, Romania, Russian Federation, United States, Canada
GlaxoSmithKline

Completed

Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Australia, Argentina, Japan, Russian Federation, Spain, Germany, Mexico, Romania, Korea, Republic of, Poland, Italy, France
GlaxoSmithKline
Parexel

Withdrawn

The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on Asthma

Asthma
GlaxoSmithKline

Completed

Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents

Asthma

United States, Argentina, Russian Federation, Mexico, France, Chile
Queen's University
Royal Victoria Hospital Of Barrie; Religious Hospitallers of Saint Joseph of...

Completed

Hypertonic Saline to Reduce Hospital Admissions in Bronchiolitis

Viral Bronchiolitis

Canada
Amphastar Pharmaceuticals, Inc.

Terminated

Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction

Asthma | Bronchospasm

United States
First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

Nebulized Salbutamol Facilitate Management of Hyperkalemia Postreperfusion During Liver Transplantation

Liver Transplantation
Chiesi Farmaceutici S.p.A.

Completed

Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms

Bronchial Asthma

Poland, Ukraine
Novartis Pharmaceuticals

Withdrawn

Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma

Asthma

3

Subscribe